PRESERVING THE MIND – INDEX
Preface – Ten Steps Toward Prevention of Dementias
Introduction – Medications and Scientific Advancements
Reflections
How to Use This Reference Guide
Abbreviations and Symbols
Terms and Concepts A to Z:
1.
5HT6 receptors, 5HT7 receptors, and neurocognitive enhancement
2.
acetaminophen and stress
3.
acetylcholine (Ach) – the memory neurotransmitter
4.
acetylcholine (Ach) – the memory neurotransmitter
5.
AchEIs (acetylcholinesterase inhibitors) and acetylcholine receptors
6.
AchM – drugs that increase AchM with resulting side effects
7.
active lifestyle and cognition
8.
addiction and dementia
9.
adenosine
10.
adrenal cortex
11.
adrenal medulla
12.
adrenergic
13.
adrenocorticotropic hormone (ACTH)
14.
advanced phase sleep syndrome
15.
affective disorders and Alzheimer’s disease
16.
afferent neuron
17.
age-associated memory impairment (AAMI)
18.
age demographics in the USA – changes over time
19.
aging and antiaging maneuvers
20.
aging and metabolic changes
21.
aging of Americans
22.
aging with a superbrain
23.
agitation and Alzheimer’s disease
24.
agitation and medication
25.
agonist
26.
AIDS and dementia
27.
alcohol addictions: treatments tried
28.
alcohol and dementia
29.
alcohol consumption has the following effects:
30.
alcohol dependency and life expectancy
31.
alcoholism, depression, anxiety, and dementia
32.
aluminum and AD (Alzheimer’s disease)
33.
Alzheimer’s dementia (AD)
34.
Alzheimer’s dementia (AD) and Abeta fragments
35.
Alzheimer’s dementia (AD) and early changes in brain chemistry
36.
Alzheimer’s dementia and histone deacetylase (HDAC)
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
Alzheimer’s dementia and PET scan
Alzheimer’s dementia – anti-amyloid drugs
Alzheimer’s dementia – behavior treatment
Alzheimer’s dementia – details
Alzheimer’s dementia – donepezil (Aricept) versus memantine (Namenda)
Alzheimer’s dementia drugs – boom and bust drugs
Alzheimer’s dementia – drugs details
Alzheimer’s dementia drugs – history
Alzheimer’s dementia functioning questions
Alzheimer’s dementia – medication considerations
Alzheimer’s dementia – progressive symptoms showing decline of brain function
Alzheimer’s dementia – purpose
Alzheimer’s dementia – questions for helpers
Alzheimer’s dementia – stages
Alzheimer’s dementia – summary of hypothetical drug treatments based on 12 theoretical causes
of AD
Alzheimer’s dementia – treatments and tools tried: from simple to complex from speculation to
research, from over-the-counter (OTC) and lifestyle changes to research; from early cognitive
delay (ECD) to AD
Alzheimer’s disease (AD) and depression
Alzheimer’s disease (AD) and hepatic metabolism
Alzheimer’s disease (AD) and intranasal insulin therapy
Alzheimer’s disease (AD) and neuroimaging brain abnormalities
Alzheimer’s disease (AD) and the parietal lobes
Alzheimer’s disease (AD) biomarkers
Alzheimer’s disease (AD), comorbidities(coexisting disorders), and drug cautions
Alzheimer’s disease (AD) – cost
Alzheimer’s disease (AD) – future treatment hopes
Alzheimer’s disease (AD) – list of drugs tried or to be tried
Alzheimer’s disease (AD) – late versus early onset
Alzheimer’s disease (AD), medications, and the P450
Alzheimer’s disease (AD) – prodromal blood test and MRI changes
Alzheimer’s disease (AD) – Rx with high dose donepezil or memantine
Alzheimer’s disease (AD) – specific details
Alzheimer’s disease (AD) – stages of decline
Alzheimer’s disease (AD) – the risk factors
Alzheimer’s disease (AD) – treatments tried
Alzheimer’s disease – methods of detection
Alzheimer’s disease – progression
Alzheimer’s disease projection
Alzheimer’s disease – tips for caregivers
Alzheimer’s drugs – nuances of interest
Alzheimer’s risk factors
Ambien (zolpidem)and insomnia in Alzheimer’s disease
anatomy of memory
animal agents of diseases with psychiatric symptoms, possible cognitive dysfunction, and other
medical symptoms
anticholinergic drugs and Alzheimer’s disease
anticholinergics – drugs with anticholinergic properties; dangers in those with Alzheimer’s
disease
antidepressants and neurogenesis
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
131.
132.
133.
antidepressants, neurotransmitter purity, and dementia
antidepressants—SSRIs, neurotransmitters, the P450, and dementia
antihistamines
antihistamines and dementia
antioxidants tried in Alzheimer’s disease (AD)
antipain medications, TENS unit, and dementia
antipsychotics in dementia
anxiety—acute and chronic: biochemistry, anatomy, and dementia
anxiety and dementia
anxiety, BDNF, and hippocampal volume, and cognition
anxiety medications: categories, dementia
apathy and Alzheimer’s disease
apathy, dopaminergic drugs and cognition
ApoE defects and AD (Alzheimer’s disease)
apolipoprotein Ee4 allele (ApoE4)
ASHD (arteriosclerotic heart disease), stress, and dementia
aspirin (ASA)
atherosclerosis, dementia, and laboratory findings
arthrosclerosis in carotid arteries
atherosclerosis in major intracranial arteries
atrial fibrillation (AF) and cognitive impairment
atypical neuroleptics – off-label use
autoimmune diseases, stress, and Alzheimer’s disease
autonomic nervous system, beta blockers, and dementia
axon
Axona
baby boomers
BDNF (bran-derived neurotropic factor)
behavioral memory technique
benzodiazepines, addiction, and dementia
benzodiazepines—possible contraindication, use in dementia
bereavement and dementia
best medicine in psychiatry
biomarkers for Alzheimer’s disease(AD)
bipolar disorder and age
bipolar disorder (BP) and cognitive impairment
black box warning and dementia
blood-brain barrier (BBB)
brain and dementia
brain areas and dementia
brain areas – brain stem
brain areas – cerebral hemispheres, four lobes
brain areas – diencephalon
brain areas – limbic system
brain lesions presenting as dementia
brain, order, and cognition
brain parts and dementia
brain parts, brain damage, and mental disorders
brain parts, cognition, and emotions
brain tumors and psychiatric drugs
B vitamin prescription products and Alzheimer’s disease
134.
135.
136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
167.
168.
169.
170.
171.
172.
173.
174.
175.
176.
177.
178.
179.
180.
181.
182.
183.
B vitamins
caffeine (1, 3, 5-trimethylxanthine)and increased cognition question
cancer and dementia
cardiovascular disorders (CVD), psychiatric disorders, aspirin, and dementia
causes of decreased cognitive functioning in the elderly
central nervous system (CNS) and dementia
cerebrum and dementia
Cerefolin NAC (L-methylfolate [6 (s)-5 MTHF] [Metafolin], methylcobalamin, Nacetylcysteine): nuances of interest in dementia
chemical neurotransmission
choice
cholesterol drugs
cholinesterase inhibitors and memantine drug interaction
cognition and alcohol
cognition and growth hormone-releasing hormone (GHRH)
cognition and sleep
cognition (decreased) and insomnia
cognition, depression, and dementia
cognitive – behavioral therapy in early cognitive delay
cognitive decline – types with increased age
cognitive delay – mini mental screening form
cognitive delay – tests for evaluating
cognitive dysfunction in the elderly – various etiologies
cognitive evaluation tools
cognitive functioning tests
cognitive enhancement and neurotechnology
cognitive impairment mild (mild cognitive impairment)
cognitive impairment not dementia (CIND)
cognitive impairment of normal aging
cognitive impairment of vascular origin (vascular cognitive impairment)
cognitive screening questions for dementia: yes or no answers
common pathways and cognitive impairment
compliance in dementia and other disorders
confirmation bias, placebo effect, and Alzheimer’s disease
conflict in dementia
confusion and dementia
constipation in dementia and other disorders
coronary artery disease (CAD)
coronary artery disease (CAD) risk factors
CREB protein (cyclic AMP response element binding protein) and dementia
Creutzfeldt-Jakob disease (CJD)
cytokines and dementia
DAT scan
decade of the brain
decision making and increasing age
deep brain stimulation (DBS) history and Alzheimer’s disease
delirium
delirium and anticholinergic toxicity
delirium and dementia compared
delirium – psychiatric treatments tried
delirium – symptom alert
184.
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
195.
196.
197.
198.
199.
200.
201.
202.
203.
204.
205.
206.
207.
208.
209.
210.
211.
212.
213.
214.
215.
216.
217.
218.
219.
220.
221.
222.
223.
224.
225.
226.
227.
228.
229.
230.
231.
232.
233.
234.
delirium—symptoms, causes, and treatments; distinguishing features for dementia
delusion
dementia
dementia (Alzheimer’s type) – a list of drugs tried
dementia (Alzheimer’s type) and PET scan
dementia—Alzheimer’s type with depression
dementia and agitation
dementia and antidepressant discontinuation
dementia and antipsychotics (SGAs)
dementia, cholinesterase inhibitors, and antipsychotics
dementia cost
dementia – Creutzfeldt-Jakob disease/CJD specifics
dementia – endocrine causes
dementia—diagnosis, evaluation, differential, causes, treatments
dementia – greatest risk factor
dementia – HIV (human immunodeficiency virus) specifics
dementia – Huntington’s disease specifics
dementia – Lewy body disease (LBD) specifics
dementia – nondrug intervention
dementia – normal pressure hydrocephalus (NPH)
dementia, nursing home residences, and other common diseases
dementia – Parkinson’s disease (PD) specifics
dementia – (Pick’s disease/frontotemporal) specifics
dementia prevalence
dementia – rapidly progressive, a differential
dementias – anatomical areas involved
dementias due to infectious protein (prion)
dementias – frequency order
dementias – summary
dementias – symptoms compared, all have decreased memory
dementias – types and percentage
dementia – sundowning
dementia – symptoms, types, treatments
dementia test – Folstein MMSE
dementia – vascular specifics
dementia versus delirium
dementia – vitamin deficiencies – causes
dementia with Lewy bodies (DLB) verses AD (Alzheimer’s disease)
18 dementias – symptom differential
dendrites
depression and 5-HTTLPR (serotonin transporter promoter region)
depression and Alzheimer’s disease (AD)
depression and BDNF levels and cognition
depression and cognitive treatment considerations in seniors
depression and dementia
depression and dementia late in life
depression and dementia risk
depression – atypical symptoms
depression – cognitive difficulties
depression, dementia, and hippocampal volume
depression, dementia and natural products
235.
236.
237.
238.
239.
240.
241.
242.
243.
244.
245.
246.
247.
248.
249.
250.
251.
252.
253.
254.
255.
256.
257.
258.
259.
260.
261.
262.
263.
264.
265.
266.
267.
268.
269.
270.
271.
272.
273.
274.
275.
276.
277.
278.
279.
280.
281.
282.
283.
284.
285.
depression, glutamate antagonists, dementia, and glutamate partial agonists
depression, heart disease, and Alzheimer’s disease
depression – medical conditions such as Alzheimer’s disease
depression, old age and Alzheimer’s disease (AD)
depression, the elderly, and vascular disease
diarrhea in dementia
differential, all have decreased memory
disability – dementia
disability form for dementia and other psychiatric maladies
discouragement and early cognitive delay
disease on the increase and decrease
domestic violence (personal and other terrorism/POT)
donepezil (Aricept)and Alzheimer’s disease
dopamine (D) and apathy effects of dementia
dopamine receptor agonists and precursors
Down syndrome and AD (Alzheimer’s disease)
drug
drug clearance
drug development phases
drug distribution
drug half-life
drug receptor
drugs of abuse in order of probable use with effects on cognition
drugs of abuse in the elderly – symptoms of alcohol withdrawal
drugs of abuse in the elderly – symptoms of heroin abuse
drugs of abuse in the elderly – symptoms of opioid withdrawal
drugs of abuse – medical and cognitive complications
drugs of abuse: TWEAK test – do you as a senior have an alcohol problem?
drugs in development – top 10 areas in 2009
drugs – top ten prescribed by psychiatrists in 2006
dry mouth in the elderly
DSM (Diagnostic and Statistical Manual of Mental Disorders) – publication dates
early cognitive delay avoidance
early cognitive delay avoidance with diet
early cognitive delay avoidance with exercise
early cognitive delay (ECD)
early cognitive delay (ECD) – conversion rate to dementia
early cognitive delay (ECD) – details
early cognitive impairment (ECI) – progression
ECT (electroconvulsive therapy) complaints
elderly
elderly and psychiatric problems
electrocardiogram (ECG or EKG)
electroconvulsive therapy (ECT)
electroencephalogram (EEG)
erroneous beliefs and memory decline
erroneous beliefs to be challenged in old age
European Consortium on Dementia (EURODEM) – risk factors for AD
evidence-based medicine (EBM) – a critique
extended preclinical phase often precedes AD (Alzheimer’s disease)
extrapyramidal side effects of neuroleptics (EPS)
286.
287.
288.
289.
290.
291.
292.
293.
294.
295.
296.
297.
298.
299.
300.
301.
302.
303.
304.
305.
306.
307.
308.
309.
310.
311.
312.
313.
314.
315.
316.
317.
318.
319.
320.
321.
322.
323.
324.
325.
326.
327.
328.
329.
330.
331.
332.
333.
334.
335.
extrapyramidal symptoms (EPS)
FDA approved drugs for AD
fear and dementia
first-pass effect of a drug
folic acid deficiency
folic acid level tests in dementia
folic acid metabolite: mechanisms of action in dementia, depression and neuropathy
free radicals and dementia
frontotemporal dementia (FTD) versus depression
functional assessment – minor to major problem in several areas
future of psychiatry: six trends with dementia and other mental disorders
generic drugs
generic drugs versus brand name drugs
genes and Alzheimer’s disease
genetic and molecular targets for new psychiatric drug development in dementia and other mental
disorders
genetics – the basics
ginkgo biloba
glucose regulation, cognitive decline, and AD (Alzheimer’s disease)
glutamate – a memory neurotransmitter
glutamate antagonists and partial agonists
glutamate in various disorders and memory issues
grief
grief, fatigue and dementia
hallucinations, delusions, and dementia
happiness infections
herpes infection
HIV – associated dementia
HIV drugs
HIV (human immunodeficiency virus) infection
HIV – neurocognitive impairment lending to dementia
HIV prevalence and dementia
HIV tests
human agency and dementia
Huntington’s dementia triad
Huntington’s disease (HD)
Huntington’s disease (HD) and pridopidine
Huntington’s disease (HD) – dementia
hyperparathyroidism
hypertension and dementia – early treatment with calcium channel blockers
hypothalamic/pituitary/adrenal axis (HPA)
imagination
inflammation and psychiatric disorders (AD, BP, MDD)
inflammation, depression, and Alzheimer’s disease
insomnia and dementia
insomnia and dementia – interesting data
insomnia, chloral hydrate, and the elderly
insomnia codes – International Classification of Diseases (ICD)
insomnia – costs
insomnia, dementia, new hypnotics, and novel hypnotics
insomnia, dementia, other mental disorders, neurochemistry, and neurocircuitry
336.
337.
338.
339.
340.
341.
342.
343.
344.
345.
346.
347.
348.
349.
350.
351.
352.
353.
354.
355.
356.
357.
358.
359.
360.
361.
362.
363.
364.
365.
366.
367.
368.
369.
370.
371.
372.
373.
374.
375.
376.
377.
378.
379.
380.
381.
382.
383.
384.
385.
386.
insomnia – details of interest
insomnia, diphenhydramine, and dementia
insomnia: pharmacologic treatments—GABA and other neurotransmitter subunits
insomnia – prevalence, the cost, the details, the types, the evaluation, the treatments
insomnia – RLS (restless legs syndrome) versus PLMS (periodic leg movements in sleep)
involuntary emotional expressive disorder (IEED)and Alzheimer’s disease
ketamine and memory loss
kindling, Alzheimer’s disease, and other mental disorders
knowledge
laboratory values: selected ones of interest in psychopharmacology and dementia
laughter and cognition in seniors
laxatives and dementia
lipids and heart disease
L-methylfolate and AD
L-methylfolate (B9), methylcobalamin (B12), acetylcysteine
magnetic resonance imaging (MRI) and dementia
marijuana, decreased cognition, many other details
medical diseases (liver, kidney) and psychiatric medications
medical diseases – most frequent in the USA in order
medical disorders – most disabling
medication and noncompliance
Mediterranean dietary pattern (MDP)
melancholia and dementia
melatonin
melatonin and Alzheimer’s disease
memantine (Namenda), NMDA antagonism, and (AD) Alzheimer’s disease
membranes
memory
memory and sedative-hypnotics
memory and slow-wave sleep
memory changes
memory improvement questions and exercises
memory, neurotransmitters, brain anatomy, and psychopharmacology
memory (recent and remote) in Alzheimer’s disease (AD)
memory techniques
memory types
memory storage
memory, words, and knowledge
mental disorders (National Comorbidity Study Replication)
mental illness – causes (genes + epigenetic influences + choices) in dementia
metabolism and “first-pas” effect
metabolism of drugs
Metanx (L-methylfolate 2.8 mg + pyridoxal 0.5 phosphate 2.5 mg + methylcobalamin 2 mg)
metformin and cognition
methylphenidate and apathy of AD (Alzheimer’s disease)
mild cognitive impairment (MCI) and Alzheimer’s dementia (AD)
mild cognitive impairment (MCI) – early cognitive delay
milieu therapy and dementia
Minirth Diet
molecular site of action of drugs
mood
387.
388.
389.
390.
391.
392.
393.
394.
395.
396.
397.
398.
399.
400.
401.
402.
403.
404.
405.
406.
407.
408.
409.
410.
411.
412.
413.
414.
415.
416.
417.
418.
419.
420.
421.
422.
423.
424.
425.
426.
427.
428.
429.
430.
431.
432.
433.
mood changes – medical causes
mood stabilizers and pregnancy risks
moral treatment history
motivation in Alzheimer’s disease
MS (multiple sclerosis) drugs
multiple sclerosis (MS) and dementia
multiple sclerosis (MS) in children – MRI changes at disease onset
multiple sclerosis (MS) – nuances of interest
multiple sclerosis (MS) – pathologies
muscle relaxants in dementia and other medical disorders
nacebo
NAC (N-acetyl cysteine) and cognition
NAC (N-acetyl cysteine) details
Namenda XR (memantine HCl extended release capsules and Alzheimer’s disease)
natural products – a medley, some with positive cognition enhancing effects
natural products of interest in mental health, in cognition, and in memory enhancement
natural products – possibly good for health and enhanced cognition
natural products – the need
natural products—top selling natural products in recent past
natural products touted to increase cognition
natural products with significant dangers
nervous tissue and dementia
neurocognitive disorder and DSM5 (Diagnostic and Statistical Manual of Mental
Disorders – Edition V)
neurogenesis and increased cognition
neuroimaging of psychiatric issues including Alzheimer’s disease
neuroleptics and the elderly
neurological examination
neurological examinations – details
neurological test considerations in movement disorders (sometimes seen in dementias)
neuron and dementia
neuropathic pain and Alzheimer’s disease
neuroplasticity, neurogenesis, and neurocircuitry
neuroplasticity – nuances of interest
neurotransmitter abnormalities in AD (Alzheimer’s disease)
neurotransmitters
neurotransmitters – the details in Alzheimer’s disease and more
neurotransmitters, receptors, and neuronal function in Alzheimer’s disease and other mental
disorders
nicotine addiction – neurotransmitters and treatments
NMDA (N-methyl-D-aspartate)
nonsteroidal anti-inflammatory drugs (NSAIDs)and the elderly
nonsteroidal medications, GI (gastrointestinal), and CV (cardiovascular) risks from least risks to
most risks
nostalgia and early cognitive delay (ECD)
Nuedexta (dextromethorphan hydrobromide 20 mg, quinidine sulfate 10 mg) and Alzheimer’s
disease
nutritional deficiencies causing dementia
obesity
obesity – an addiction or not
obesity and binge eating
434.
435.
436.
437.
438.
439.
440.
441.
442.
443.
444.
445.
446.
447.
448.
449.
450.
451.
452.
453.
454.
455.
456.
457.
458.
459.
460.
461.
462.
463.
464.
465.
466.
467.
468.
469.
470.
471.
472.
473.
474.
475.
476.
477.
478.
479.
480.
481.
482.
483.
484.
obesity and body mass index (BMI)
obesity and cognitive decline
obesity and dementia – other nuances of interest
obesity, depression, dementia, and food addiction
obesity on the increase – Alzheimer’s disease comorbidity
obstructive sleep apnea (OSA) and later dementia
obstructive sleep apnea (OSA) – cognitive dysfunction
obstructive sleep apnea (OSA) – future possible dementia: nuances of interest
old age, bereavement, depression, stress, and dementia
omega-3 fatty acids (ω-3 fatty acids)and memory
omega-3 fatty acids (eicosapentaenoic acid or EPA and docosahexaenoic acid or DHA) – sources
omega-3 fatty acids (FAs) – specifics
opiates, pain, psychiatry, abuse, and dementia – the details
opioids and dementia
opioid types
opioid use complications including cognitive delay
opium history
osteoporosis, dementia, and depression
oxidative stress and increased aging
P450 isoenzyme substrates, inhibitors, and inducers – drug metabolizing
P450 metabolic enzyme system – note the (*) for Alzheimer’s disease drugs
pain: chronic – in the elderly
pain, chronic pain, central nervous system (CNS) pain states
pain – dates of prominent opioid pain medications
pain – medication choices
pain perception, 5HT, and NE spinal pathways
pain, pleasure, and the brain
pain – selected drugs and TENS units
pain types
Parkinson dementia causes
Parkinsonism or Parkinson’s disease (PD)
Parkinsonism, psychiatric disorders, L-dopa, and other treatments of Parkinsonism
Parkinson’s disease (PD) – nuances
partition coefficient
people of psychology and psychiatry – their concepts in memory
periodic limb movements during sleep (PLMS) and the elderly
peripheral neuropathy (PN)
peripheral nervous system (PNS) diagram
personality and dementia
phantom pain
pharmacodynamics
pharmacogenomics, Alzheimer’s disease, and much more
pharmacokinetic terms and Alzheimer’s disease
pharmacology resistance – causes of medication resistance
phosphatidylserine
photographic memory
Pick’s disease (PiD) dementia
pineal gland
pituitary gland
placebo
placebo response and the µ-opioid system
485.
486.
487.
488.
489.
490.
491.
492.
493.
494.
495.
496.
497.
498.
499.
500.
501.
502.
503.
504.
505.
506.
507.
508.
509.
510.
511.
512.
513.
514.
515.
516.
517.
518.
519.
520.
521.
522.
523.
524.
525.
526.
527.
528.
529.
530.
531.
532.
533.
534.
plasma protein binding of drugs
polypharmacy and Alzheimer’s disease
polysomnography (PSG)
positron emission tomography (PET) and dementia
potency
potency versus efficacy of drugs
prevalence of chronic medical illnesses
prognosis in Alzheimer’s disease
pseudobulbar affect (PBA) in Alzheimer’s disease: overview and treatments
pseudomentia
psychiatric assessments in the near future
psychiatric diagnosis in the future for dementia
psychiatric drugs, the cytochrome P450 enzymes, and Alzheimer’s disease drugs
psychiatric manifestations of AD (Alzheimer’s disease)
psychiatric medications – helping or hurting memory
psychiatric medications – liquid formulations in various disorders including Alzheimer’s disease
drugs
psychiatrist and Alzheimer’s disease
psychiatry and the public
psychologist
psychopharmacology and dementia
psychopharmacology: basic principles in drugs for dementia and comorbid (coexisting) disorders
psychopharmacology – drug dosing nuances, doses tried
psychosis and dementias
psychosis – laboratory considerations
psychostimulants
psychotherapy – changes in brain structure and increased cognition
psychotherapy in dementias and other psychiatric disorders
psychotherapy – SPT (supportive psychotherapy)
psychotic processes and dementias
psychotic symptoms from medical diseases and Alzheimer’s disease (AD)
psychiatry
QT prolongation on EKG in the elderly
quetiapine (Seroquel)
ramelteon (Rozerem) in dementia
regret
Remeron (mirtazipine)
REM sleep behavior disorder (RBD)
renal disease and psychiatric issues
resilience and dementia
resources for the elderly
restless legs syndrome (RLS) and periodic limb movements (PLM) in Alzheimer’s
disease
restless legs syndrome (RLS) in the elderly
restless legs syndrome (RLS) – nuances of interest
restless legs syndrome (RLS), the elderly, and the brain
reticular activating system (RAS)
retirement, old age, and early cognitive delay
Risperdol (risperidone) and dementia
rivastigmine (Exelon) and Parkinson’s dementia (PD)
routes of drug administration with examples
sad affect in early cognitive delay (ECD)
535.
536.
537.
538.
539.
540.
541.
542.
543.
544.
545.
546.
547.
548.
549.
550.
551.
552.
553.
554.
555.
556.
557.
558.
559.
560.
561.
562.
563.
564.
565.
566.
567.
568.
569.
570.
571.
572.
573.
574.
575.
576.
577.
578.
579.
580.
581.
582.
583.
584.
585.
Saint John’s wort (hypericum perforatum)
SAMe – mechanisms of action in Alzheimer’s disease (AD)
SAMe (S-adenosyl-L-methionine) and Alzheimer’s disease (AD)
Savella (milnacipran) and pain in the elderly
schizophrenia, relapses, and brain volume
science
scientific research – possible flaws in Alzheimer’s disease research
sedative-hypnotics – nuances of interest
sedative-hypnotics, opioids, and smoking in older Americans
selective serotonin-norepinephrine reuptake inhibitors (SNRIs) and the elderly
selective serotonin reuptake inhibitors (SSRI) and the elderly
selegiline (Eldepryl)
serotonin-dopamine antagonists (SDA’s—atypical neuroleptics)
serotonin/norepinephrine reuptake inhibitor (SNRI)
seven steps to preserving memory
sexually transmitted diseases (STDs) and decreased cognition
side effects of drugs with antidepressant effects
side effects of psychiatric medications
signal transduction
sleep
sleep and noise
sleep apnea
sleep apnea and cognition
sleep cycles
sleep disordered breathing (SDB) and comorbid dementia
sleepiness (excessive daytime sleepiness or EDS)
sleep hygiene
sleep latency
sleep questions
sleep stages, medications, and various factors
sleep, wakefulness –brain nuclei and neurotransmitters
sleepiness in daytime – a summary of prevalence, causes, and treatments
SNRIs – mechanisms of action
soma
somatic nervous system
somatization
special populations
SSRI antidepressants and gastrointestinal (GI) bleed
SSRI discontinuation syndrome
SSRIs and bone loss
SSRIs and gastrointestinal (GI) bleeding
statins, decreased cholesterol, and depression
statistics
steroids
stimulants and Alzheimer’s disease
stress
stress and decreased memory
stress and eventual effects on the body
stress and mental disorders
stress chart – how Alzheimer’s disease develops
stress circuitry and decreased memory
586.
587.
588.
589.
590.
591.
592.
593.
594.
595.
596.
597.
598.
599.
600.
601.
602.
603.
604.
605.
606.
607.
608.
609.
610.
611.
612.
613.
614.
615.
616.
617.
618.
619.
620.
621.
622.
623.
624.
625.
626.
627.
628.
629.
630.
631.
632.
633.
634.
635.
636.
stroke
stroke and statins
stroke, atherosclerosis, and vascular dementia (VD)
stroke, depression and dementia
stroke – possible benefits of psychiatric drugs
stroke – stress
substance abuse – nuances of interest
substance P (SP)
substance use disorder treatments and dementia avoidance
suicide and cholesterol
suicide and old age
suicide and psychopharmacology
sympathetic nervous system
symptoms of psychiatric disorders –acronym learning devices
symptoms – self-rating report
synapse
syncope
systemic lupus erythematosis (SLE)
T3 and receptor numbers
TBIs and axonal injury
TBI (traumatic brain injury) and insomnia Rx
telemedicine
telemental health
telepsychiatry and Alzheimer’s disease
tension headaches
testosterone
therapeutic alliance aids
therapeutic index (TI)
thiamine (B1) deficiency – causes
TMS – mechanisms of action
tobacco
tolerance
toxins causing dementia
traditional categories of psychiatric drugs
traumatic brain injury (TBI)
traumatic brain injury (TBI) and dementia
traumatic brain injury (TBI) – nuances of interest
traumatic brain injury (TBI) – possible symptoms
traumatic brain injury (TBI) – treatments tried
trazodone (Desyrel)
trazadone – insomnia
treatment resistance
tremors
Ultram (tramadol)
valproate (Depakote, Depakene)
valproate – drug interactions
valproic acid (Depakote)
vascular dementia
vayacog
vegetative patients and awareness
vertigo
637.
638.
639.
640.
641.
642.
643.
644.
645.
646.
647.
648.
649.
650.
651.
652.
653.
vitamin D
vitamin D, cognitive dysfunction, depression, and AD (Alzheimer’s disease)
vitamin D – nuances of interest
vitamins
volume of distribution (VD)
wake system of the brain
warnings
white matter disorder causes
Wilson’s disease
wisdom
wisdom circuitry
withdrawal
worry – seven steps to fighting worry
zaleplon (Sonata)
Zanaflex (tizanidine hydrochloride)
Zoloft (sertraline)
Zolpidem (Ambien)
Appendix A – Vocabulary Word Exercises for Memory Enhancement
Vocabulary Words (A to Z)
Appendix B – Knowledge Exercises for Memory Enhancement
Knowledge
Tests for Super Agers
Pre-Test
History I
History II
Historical Ages
History – Famous People
History of Ideas
Explorers
Dynasties
Government
Documents
Amendments to the United States Constitution
Pictures on Coins and Bills
World Geography
Literature
Music
Art and Architecture
Concepts for Chemistry
Biology
Neurology and Psychiatry
Concepts from Physics
Psychology and Memory Improvement
English
Math
Concepts from Physics and Math
Reasoning Exercises
Judgment Concepts and Exercises
Math Exercised
Conceptual and Abstract Thinking Exercises
Knowledge Review Test
Bibliography
About the Author